Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype.

Biochemical and biophysical research communications - 1 Jan 2010

Armel Thomas Z, Leinwand Leslie A

Abstract excerpt

Hypertrophic cardiomyopathy (HCM) is a common, autosomal dominant disorder primarily characterized by left ventricular hypertrophy and is the leading cause of sudden cardiac death in youth. HCM is caused by mutations in several sarcomeric proteins, with mutations in MYH7, encoding beta-MyHC, bein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Cardiomyopathy, Hypertrophic
Share to Glutamic Acid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lysine

Share to Protein Stability

Share to Protein Structure, Secondary

Share to Thermodynamics

Share to Ventricular Myosins

Source

Open in PubMed Open full text

Identifiers

PMID: 19913502
DOI: 10.1016/j.bbrc.2009.11.062
PMCID: PMC2821741

Genes

MYH7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-19913502-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype.PMID 19913502Read ↗

Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes.Semantic proximity Read ↗

Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms.Semantic proximity Read ↗

Hypertrophic cardiomyopathy: from mutation to functional analysis of defective protein.Semantic proximity Read ↗

Hypertrophic cardiomyopathy ß-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super-relaxed stateSemantic proximity Read ↗

Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor functionSemantic proximity Read ↗

A myosin hypertrophic cardiomyopathy mutation disrupts the super-relaxed state and boosts contractility by enhanced actin attachmentSemantic proximity Read ↗

Mutations in the catalytic domain of human β-cardiac myosin that cause early onset hypertrophic cardiomyopathy significantly increase the fundamental parameters that determine ensemble force and velocitySemantic proximity Read ↗

Divergent molecular phenotypes in point mutations at the same residue in beta-myosin heavy chain lead to distinct cardiomyopathiesSemantic proximity Read ↗

Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.Semantic proximity Read ↗

Cardiomyopathy: a systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestations.Semantic proximity Read ↗

Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.